Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06591091
PHASE2

Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression

Sponsor: University of Illinois at Chicago

View on ClinicalTrials.gov

Summary

The goal of this study is to find out if the antihistamine, clemastine, can make the white matter in the brain better in older adults with depression. The study will also determine whether this improvement can make antidepressant treatment work better, reduce depressive symptoms, and improve memory and thinking.

Key Details

Gender

All

Age Range

60 Years - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2025-09

Completion Date

2026-03

Last Updated

2025-09-04

Healthy Volunteers

No

Conditions

Interventions

DRUG

Clemastine Fumarate

Listed in arm/group description

DRUG

Placebo

Listed in arm/group description